文献速递血液净化与透析慢性肾脏病

腹膜透析导管置入时估算肾小球滤过率与透析相关并发症的关联

Association of Estimated GFR at the Time of Peritoneal Dialysis Catheter Insertion With Dialysis-Related Complications.
PubMed 文献 · Am J Kidney Dis · 2026-10-26

本研究为北美腹膜透析导管登记系统的回顾性队列研究,纳入1537例置管患者,探讨置管时eGFR水平与90天内PD相关并发症的关系。结果显示eGFR≤9组并发症风险为22% vs 18%(P=0.4),但在该组内eGFR每降低1 ml/min并发症风险增加10%(aHR 1.10,95%CI 1.01–1.19);置管后30天内开始PD与并发症风险增加相关(aHR 3.15,95%CI 1.48–6.67)。

要点

  • 置管时eGFR≤9 ml/min/1.73m²者占67%,其90天并发症风险与eGFR>9组无显著差异。
  • 在eGFR≤9组内,eGFR每降低1 ml/min,并发症风险增加10%。
  • 置管后30天内启动PD与并发症风险增加约3倍相关。

核心结论

  • 在置管时eGFR<9 ml/min/1.73m²的患者中,eGFR越低,PD相关并发症风险越高。
  • 置管后30天内开始PD也与并发症风险增加相关。
  • 在较高eGFR时置管并启动PD可能减少早期临床并发症。

研究设计与样本

  • 回顾性队列研究,数据来自北美腹膜透析导管登记系统。
  • 共纳入1537例腹膜透析导管置入患者。
  • 暴露为置管时eGFR水平,分为≤9 ml/min/1.73m²或>9 ml/min/1.73m²。
  • 采用病因特异性比例风险模型进行分析。

主要发现

  • eGFR≤9组67%,>9组33%;≤9组更年轻、女性更多、合并症更少。
  • 主要结局(90天内PD相关并发症)风险:eGFR≤9组22% vs >9组18%(P=0.4)。
  • 在eGFR≤9组内,eGFR每降低1 ml/min,并发症风险增加10%(aHR 1.10,95%CI 1.01–1.19)。
  • 置管后30天内开始PD与并发症风险增加相关(aHR 3.15,95%CI 1.48–6.67)。
  • 常见并发症包括引流不畅(7%)、渗漏(3%)和疼痛(3%);两组转血液透析无差异(aHR 0.93,95%CI 0.60–1.45)。

临床怎么用

  • 对于计划腹膜透析的CKD患者,可考虑在eGFR较高时置管并启动PD,以减少早期并发症。
  • 置管后应避免过早(30天内)启动PD,以降低并发症风险。
  • 对置管时eGFR极低(如<9 ml/min/1.73m²)的患者,需加强早期并发症监测。

局限性

  • eGFR值未标准化,且未在透析启动时评估。
  • 未评估透析前护理情况。
  • 未评估嵌入式导管的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Guidelines recommend waiting for uremia- or volume-related symptoms before initiating dialysis for chronic kidney disease (CKD), irrespective of modality. We speculated that the use of these guidelines may promote greater peritoneal dialysis (PD) related complications following PD catheter placement. This study investigated whether lower estimated glomerular filtration rate (GFR) at the time of PD catheter insertion was associated with greater PD-related complications. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: Patients represented in the North American PD catheter registry. EXPOSURES: EGFR levels at the time of PD catheter insertion categorized as ≤9 ml/min/1.73 m2 or >9 ml/min/1.73 m2. OUTCOMES: The primary outcome was PD-related complications within 90 days of insertion, and the secondary outcome was the conversion of dialysis modality to hemodialysis. ANALYTICAL APPROACH: Cause-specific proportional hazards models. RESULTS: Among 1,537 patients with PD catheter insertions, 67% had a pre-dialysis eGFR ≤ 9 ml/min/1.73 m2 and 33% an eGFR >9 ml/min/1.73 m2. Patients with eGFR ≤9 were younger, more likely to be female, and had fewer comorbidities. The risk of complications in the eGFR ≤9 ml/min/1.73 m2 group was 22% versus 18% in the eGFR >9 ml/min/1.73 m2 group (p-value 0.4). Within the eGFR ≤9 ml/min/1.73 m2 group, when eGFR was modeled as a continuous variable, there was a 10% higher risk of complications for each 1 ml/min lower eGFR (aHR was 1.10; 95% CI: 1.01 to 1.19). Starting PD within 30 days of insertion was associated with an increased risk of experiencing complications (aHR 3.15, 95% CI 1.48, 6.67). Common PD-related complications included flow restrictions (7%), leaks (3%), and pain (3%). There was no detectable difference in conversion to hemodialysis between the groups, aHR 0.93 (95% CI 0.60 to 1.45). LIMITATIONS: eGFR values were not standardized and were not assessed at dialysis initiation. No assessment of pre-dialysis care. Impact of embedded catheters. CONCLUSIONS: In this multicenter study, the risk of PD-related complications was greater at lower eGFR levels among patients with eGFR <9 ml/min/1.73 m2 at the time of catheter placement. Initiating PD during the first 30 days after catheter insertion was also associated with increased risk. These findings suggest that inserting PD catheters and initiating PD at higher eGFRs may minimize clinical complications during the early period of PD treatment.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Dhoot A, Quinn RR, Clarke A, et al. Association of Estimated GFR at the Time of Peritoneal Dialysis Catheter Insertion With Dialysis-Related Complications. Am J Kidney Dis. 2026. PMID: 42933785. doi:10.1053/j.ajkd.2026.06.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。